Defunct Company
Total Trials
5
As Lead Sponsor
As Collaborator
0
Total Enrollment
306
NCT01300533
A Study of BIND-014 Given to Patients With Advanced or Metastatic Cancer
Phase: Phase 1
Role: Lead Sponsor
Start: Jan 31, 2011
Completion: Feb 29, 2016
NCT01792479
A Phase 2 Study to Determine the Safety and Efficacy of BIND-014 (Docetaxel Nanoparticles for Injectable Suspension) as Second-line Therapy to Patients With Non-Small Cell Lung Cancer
Phase: Phase 2
Start: Apr 30, 2013
Completion: Apr 30, 2016
NCT01812746
A Phase 2 Study to Determine the Safety and Efficacy of BIND-014 (Docetaxel Nanoparticles for Injectable Suspension), Administered to Patients With Metastatic Castration-Resistant Prostate Cancer
NCT02283320
A Study of BIND-014 (Docetaxel Nanoparticles for Injectable Suspension) as Second-line Therapy for Patients With KRAS Positive or Squamous Cell Non-Small Cell Lung Cancer
Start: Sep 30, 2014
NCT02479178
A Study of BIND-014 in Patients With Urothelial Carcinoma, Cholangiocarcinoma, Cervical Cancer and Squamous Cell Carcinoma of the Head and Neck
Start: Jun 30, 2015
Completion: Jan 31, 2020